Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer.
Conditions: Breast Cancer Interventions: Drug: Tamoxifen 10 MG; Drug: Exemestane 25 MG Sponsors: Andrea DeCensi; Dana-Farber/Brigham and Women ' s Cancer Center; Herbert Irving Comprehensive Cancer Center; Istituto Europeo di Oncologia; Breast Cancer Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Aromatase inhibitors or tamoxifen Sponsors: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Maintenance Hormonal Therapy and DLBCL
Conditions: Diffuse Large B Cell Lymphoma Interventions: Drug: Tamoxifen 20mg Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Breast Cancer & Antiestrogenic Therapy & Brain
Conditions: Breast Cancer Female; Healthy Female; Menopause; Anti-estrogenic Therapy Interventions: Drug: Tamoxifen; Drug: Letrozole; Drug: Letrozole + GnRH Sponsors: International Research Training Group 2804; German Research Foundation; University Hospital Tuebingen; Uppsala University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; HER2-positive Breast Cancer; Breast Cancer Interventions: Drug: Trastuzumab emtansine; Drug: Pertuzumab Injection; Drug: Docetaxel; Drug: Tamoxifen; Drug: Letrozole; Drug: Goserelin Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
Conditions: Pancreatic Cyst; Pancreatic Mucinous Cystic Neoplasm Interventions: Drug: Tamoxifen 20mg Sponsors: University of Nebraska Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Letrozole; Drug: Anastrozole; Drug: Exemestane; Drug: Tamoxifen Sponsors: Region Örebro County; Mid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala, Sweden Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Conditions: Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ Interventions: Procedure: Biospecimen Collection; Procedure: Mammography; Drug: Omega-3-Acid Ethyl Esters; Other: Questionnaire Administration; Procedure: Random Periareolar Fine-Needle Aspiration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Conditions: Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ; Estrogen Receptor-Positive Breast Carcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Mammography; Other: Questionnaire Administration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Unresectable HER2-Negative Breast Carcinoma; Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma; Metastatic HER2-Negative Breast Carcinoma; Metastatic Hormone Receptor-Positive Breast Carcinoma Interventions: Drug: Abemaciclib; Drug: Anastrozole; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Diagnostic Imaging; Drug: Exemestane; Other: Fludeoxyglucose F-18; Drug: Fluorine F 18 Fluoro Furanyl Norprogesterone; Drug: Fulvestrant; Biological: Gonadotropin-releasin...
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
Conditions: Metastatic Breast Cancer; Tumor; Muscle Neoplasms; Chronic Pain Interventions: Drug: Method(s)1 Attribution; Drug: Method(s)2 Attribution, Sponsors: DR. DIANE CHISESI NFS. MD. PHD.; IRB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Conditions: Ductal Carcinoma in Situ Interventions: Drug: Tamoxifen; Drug: Exemestane; Drug: Letrozole; Drug: Anastrazole; Drug: T+Ai; Drug: Elacestrant Sponsors: QuantumLeap Healthcare Collaborative Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Conditions: BRCA Mutation; PALB2 Gene Mutation; Ductal Carcinoma in Situ; Lobular Carcinoma in Situ Interventions: Drug: Tamoxifen 10 Mg Tablet; Other: Intermittent caloric restriction; Behavioral: Step counter Device Sponsors: European Institute of Oncology; Ente Ospedaliero Ospedali Galliera; Istituto Oncologico Veneto IRCCS; Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
